What we do Kabra Drugs Ltd manufactures and trades pharmaceutical products including ether derivatives and disinfectants, serving the Indian market with over 500 products. |
Founded in 1,989 |
Market share Only manufacturer of ether derivatives in Madhya Pradesh and sole Indian manufacturer of antimicrobial hand wash gel and disinfectants. |
Problem solved Providing high-quality, innovative pharmaceutical and disinfectant products to meet diverse medical and hygiene needs. |
Top clients or who we serve B2B and B2C customers across India, including supply to the Ministry of Defence. |
Key management N. Aravind (Managing Director), Kuniamuthur Nanjappan Anand (Executive Director), B V Ananth Kumar (Whole Time Director & CFO). |
Our journey and innovations Established in 1989, commercial production started in 1991; expanded to disinfectants including antimicrobial gels; implemented cost reduction amid working capital challenges. |
Where we operate Pan-India presence with manufacturing unit in Indore, Madhya Pradesh. |
Top products or what we offer Ether derivatives like Diethyl Ether, Ethyl Chloride Spray, surgical products, 500+ pharma products, disinfectants including hand sanitizers and antimicrobial gels. |
Top brands Not explicitly mentioned; flagship includes antimicrobial hand wash gel - sole manufacturer in India. |
Raw materials needed Ether and related chemical derivatives for pharmaceuticals; disinfectant raw materials. |
Raw materials supplier Details not specified. |
Recurring vs cyclical contribution Revenue currently minimal due to operational pause; historically sales from pharmaceutical manufacturing; revenue cyclic with industry trends. |
Our industry position Niche leadership as sole ether derivatives manufacturer in region; unique disinfectant product offerings. |
Financial highlights FY 2024-25 loss of Rs. 1.09 crore; no revenue reported; total income mainly other income Rs. 64.02 lakh. |
Geographical revenue split Primarily domestic Indian market; no export noted. |
Order book - |
Whats driving growth Innovation in specialty pharma products; expanding disinfectant range; government contracts. |
Our future plans Cost reduction measures to resume operations; aiming to optimize working capital and product expansion. |
Our green promise - |
Our people and values Commitment to ethics, diversity, and zero tolerance for workplace harassment; emphasizes employee engagement. |
Key challenges ahead Working capital constraints limiting operations; need for sustaining innovation and market share. |
Interesting facts Only manufacturer of antimicrobial hand wash gel in India; registered supplier to Ministry of Defence. |
Risks and strategy Financial losses pose risk; strategy includes cost curtailment and diversification of product portfolio. |
